Revvity, Inc.RVTYNYSE

Overview Intelligence Charts News Fundamentals DCF Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Latest News

businesswire.com

Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

WALTHAM, Mass.--(BUSINESS WIRE)-- #LifeSciences--Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making their debut at the conference in Boston, February 7-11, are the Opera Phenix OptIQ™ high-content screening system, the EnVision Nexus™ One multimode plate reader, and the AssayMate™ workstation, alongside other recently introduced solutions spanning sample preparation,.

seekingalpha.com

Revvity: Close To A Buy, Not Quite There

Diagnostics is driving Revvity, Inc. growth, especially outside China. Signals software a standout: high-teens growth, SaaS ARR +40%. China immunodiagnostics and NIH funding remain key drags.

zacks.com

Here's Why Revvity (RVTY) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

benzinga.com

Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results

Revvity Inc. (NYSE: RVTY) on Monday reported better-than-expected earnings for the fourth quarter.

gurufocus.com

Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic Growth Initiatives

Adjusted EPS: $5.06 for the full year, surpassing initial guidance.Organic Growth: 3% for the year, within original guidance range.Diagnostic Segment Organic G

seekingalpha.com

Revvity, Inc. (RVTY) Q4 2025 Earnings Call Transcript

gurufocus.com

Revvity's Strong Performance Overshadowed by Market Uncertainty

Revvity's (RVTY) stock is trading lower despite achieving its largest EPS upside in the past five quarters. The company reported a revenue growth of 5.9% year-o

zacks.com

Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates

RVTY stock climbs after Q4 adjusted EPS of $1.70 top estimates with revenue improving 5.9% to $772.1 million.

zacks.com

Revvity (RVTY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Revvity (RVTY) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com

Revvity (RVTY) Q4 Earnings and Revenues Beat Estimates

Revvity (RVTY) came out with quarterly earnings of $1.7 per share, beating the Zacks Consensus Estimate of $1.63 per share. This compares to earnings of $1.42 per share a year ago.

reuters.com

Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter

Medical equipment maker Revvity handily beat fourth-quarter estimates and forecast 2026 revenue and profit above Wall Street expectations on Monday, betting on continued strength in its diagnostics business even as weakness in academic research funding persists.

businesswire.com

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today reported financial results for the fourth quarter and full year ended December 28, 2025. Fourth Quarter 2025 The Company reported GAAP earnings per share of $0.87, as compared to $0.78 in the same period a year ago. Revenue for the quarter was $772 million, as compared to $729 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $112 million, as compared to $119 million for t.

zacks.com

Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery?

RVTY's Q4 results are likely to benefit from early demand recovery signs in Life Sciences, but China Diagnostics headwinds may limit earnings upside.

zacks.com

Curious about Revvity (RVTY) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Revvity (RVTY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

businesswire.com

Revvity Board Declares Quarterly Dividend

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on May 8, 2026 to all shareholders of record at the close of business on April 17, 2026. About Revvity At Revvity, “impossible” is inspiration, and “can't be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from disco.

zacks.com

Revvity (RVTY) Earnings Expected to Grow: Should You Buy?

Revvity (RVTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

defenseworld.net

Universal Beteiligungs und Servicegesellschaft mbH Sells 24,911 Shares of Revvity Inc. $RVTY

Universal Beteiligungs und Servicegesellschaft mbH cut its position in Revvity Inc. (NYSE: RVTY) by 21.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 90,911 shares of the company's stock after selling 24,911 shares during the period. Universal

zacks.com

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?

Revvity (RVTY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

seekingalpha.com

Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio Activity

Online travel agency Expedia, our top overall contributor in Q4, drove performance in the consumer discretionary sector. Our top performers in the energy and financials sectors were NOV, a provider of oilfield equipment, technology and expertise, and First Citizens, a North Carolina-based bank. Our largest new purchase was Houston-headquartered Prosperity BancShares, the fifth-largest bank in Texas.

zacks.com

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Revvity's diagnostics strength and fast-growing Signals Software support long-term growth, even as macro pressures and weak funding linger.

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance